Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Refractory Heartburn: A Challenging Problem in Clinical Practice (2018)

  • Authors:
  • USP affiliated authors: MORAES FILHO, JOAQUIM PRADO PINTO DE - FM
  • USP Schools: FM
  • DOI: 10.1007/s10620-018-4927-5
  • Subjects: REFLUXO GASTROESOFÁGICO; SINAIS E SINTOMAS; FARMACOTERAPIA; FÁRMACOS; SISTEMA DIGESTÓRIO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Informações sobre o DOI: 10.1007/s10620-018-4927-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DOMINGUES, Gerson; MORAES-FILHO, Joaquim Prado P. Refractory Heartburn: A Challenging Problem in Clinical Practice. Digestive diseases and sciences, Dordrecht, v. 63, n. 3, p. 577-582, 2018. Disponível em: < http://dx.doi.org/10.1007/s10620-018-4927-5 > DOI: 10.1007/s10620-018-4927-5.
    • APA

      Domingues, G., & Moraes-filho, J. P. P. (2018). Refractory Heartburn: A Challenging Problem in Clinical Practice. Digestive diseases and sciences, 63( 3), 577-582. doi:10.1007/s10620-018-4927-5
    • NLM

      Domingues G, Moraes-filho JPP. Refractory Heartburn: A Challenging Problem in Clinical Practice [Internet]. Digestive diseases and sciences. 2018 ; 63( 3): 577-582.Available from: http://dx.doi.org/10.1007/s10620-018-4927-5
    • Vancouver

      Domingues G, Moraes-filho JPP. Refractory Heartburn: A Challenging Problem in Clinical Practice [Internet]. Digestive diseases and sciences. 2018 ; 63( 3): 577-582.Available from: http://dx.doi.org/10.1007/s10620-018-4927-5

    Referências citadas na obra
    van Vakil N, Zanten S, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920.
    Katz OP, Gerson LB, Vela FM. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.
    Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: what do they have and how should be managed? Neurogastroenterol Motil. 2015;27:1195–1201.
    Domingues G, Moraes-Filho JPP. Noncompliance is an impact factor in the treatment of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol. 2014;8:761–765.
    Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J. Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol. 2016;13:281–294.
    Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. FGIDs: esophageal disorders. Gastroenterology. 2016;150:1368–1379.
    Lawenko RM, Lee YY. Evaluation of gastroesophageal reflux disease using the Bravo capsule pH system. J Neurogastroenterol Motil. 2016;22:25–30.
    Herregods TVK, Troelstra M, Weijenborg PW, Bredenoord AJ, Smout AJPM. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterol Motil. 2015;27:1267–1273.
    Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut. 2002;51:885–892.
    Fock KM, Talley N, Goh KL, Sugano K, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an uptdate focusing on refractory reflux disease and Barrett´s oesophagus. Gut. 2016;65:1402–1415.
    Maradey-Romero C, Kale H, Fass R. Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol. 2014;48:584–589.
    Dal-Paz K, Moraes-Filho JPP, Navarro-Rodriguez T, Eisig JN, Barbuti R, Quigley EM. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus. 2012;25:107–113.
    Fass R, Frazier R. The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. Therap Adv Gastroenterol. 2017;10:243–251.
    Barrison AF, Jarboe LA, Weinberg BM, Nimmagadda K, Sullivan LM, Wolfe MM. Patterns of proton pump inhibitor use in clinical practice. Am J Med. 2001;111:469–473.
    Hershcovici T, Fass R. Step-by-step management of refractory gastroesophageal reflux disease. Dis Esophagus. 2013;26:27–36.
    Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, Barbuti RC, Chinzon D, Quigley EM. Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics. 2009;64:785–790.
    Ichikawa H, Sugimoto M, Sugimoto K, Andoh A, Furuta T. Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis. J Gastroenterol Hepatol. 2016;31:716–726.
    Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–1598.
    Nakagawa K, Koike T, Iijima K, et al. Characteristics of symptomatic reflux episodes in japanese proton pump inhibitor-refractory non-erosive reflux disease patients. World J Gastroenterol. 2015;21:13352–13359.
    Xiao Y, Liang M, Peng S, Zhang N, Chen M. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring. J Gastroenterol Hepatol. 2016;31:350–354.
    Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-esophageal reflux refractory to proton pump inhibitors. Gut. 2003;52:1397–1402.
    Boeckxstaens GE, Beaumont H, Mertens V, et al. Effects of lesogaberan on reflux and lower esophageal sphincter functions in patients with gastroesophageal reflux disease. Gastroenterology. 2010;139:409–417.
    Gerson LB, Huff FJ, Hila A, et al. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2010;105:1266–1275.
    Richter J. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol. 2007;4:25.
    Molina-Infante J, Ferrando-Lamana L, Mateos-Rodriguez JM, Perez-Gallardo B, Prieto-Bermeio AB. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008;14:26.

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2019